| Bid Price | 0.07p | High Price | 0.08p |
|---|
| Ask Price | 0.09p | Low Price | 0.08p |
|---|
| Open Price | 0.08p | Spread | 11.76% |
|---|
| Prev Close | 0.08p | Volume | 3,330,747 |
|---|
Nuformix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 0.08 | 0.08 | 0.08 | 0.08 | 3,330,747 |
| Aug 1, 2025 | 0.08 | 0.08 | 0.08 | 0.08 | 6,471,394 |
| Jul 31, 2025 | 0.08 | 0.08 | 0.08 | 0.08 | 8,508,269 |
| Jul 30, 2025 | 0.08 | 0.08 | 0.08 | 0.08 | 7,529,050 |
| Jul 29, 2025 | 0.08 | 0.08 | 0.07 | 0.08 | 57,485,013 |
Nuformix PLC Information
| Name | Nuformix PLC | Index | |
|---|
| ISIN | GB00BYW79Y38 | Epic | NFX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 2,000,000 | Trading Status | Closed |
|---|
| Shares in Issue | 1.70 bn | Prev Close | 0.08p |
|---|
| PE Ratio | | Market Cap | £1.36 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.61147 | Quick Ratio | 0.587219 |
|---|
Nuformix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 05/11/24 | PLAC | Daniel Gooding | RES | 12,000,000 @ £0.00 | £6,000.00 |
| 05/11/24 | PLAC | Madeleine Kennedy | NED | 22,000,000 @ £0.00 | £11,000.00 |
| 05/11/24 | PLAC | Julian Gilbert | NED | 22,000,000 @ £0.00 | £11,000.00 |
| 10/01/22 | BUY | Alastair Riddell | RES | 400,000 @ £0.01 | £4,700.00 |
| 16/09/21 | BUY | Alastair Riddell | RES | 350,000 @ £0.01 | £4,725.00 |
| 30/03/21 | PLAC | Karl Keegan | RES | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Madeleine Kennedy | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Julian Gilbert | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Anne Brindley | RES | 500,000 @ £0.02 | £10,000.00 |
| 05/02/20 | SELL | David Tapolczay | RES | 650,000 @ £0.09 | £56,550.00 |
Nuformix PLC News
